/manager/Index ${session.getAttribute("locale")} 5 Final 10-year results of the Breast International Group 2–98 phase III trial and the role of Ki67 in predicting benefit of adjuvant docetaxel in patients with oestrogen receptor positive breast cancer /manager/Repository/uon:18606 Sat 24 Mar 2018 08:01:03 AEDT ]]> p-STAT3 in luminal breast cancer: Integrated RNA-protein pooled analysis and results from the BIG 2-98 phase III trial /manager/Repository/uon:32265 Mon 23 Sep 2019 13:56:46 AEST ]]> Tumor-infiltrating lymphocytes and prognosis: a poled individual patient analysis of early-stage triple-negative breast cancers /manager/Repository/uon:34339 Mon 03 Feb 2020 11:52:07 AEDT ]]>